In addition, cumulative evidences suggest that changes in SYNE1 expression levels, somatic mutations, promoter methylation level, and single-nucleotide polymorphisms are related to the occurrence and development of lung cancer (20), oral cancer (21), hepatocellular carcinoma (22), and gastric cancer (23). Here, SYNE1 is linked to lung cancer.